Extracorporeal Membrane Oxygenation (ECMO): An Option for Cardiac Reccovery from Advanced Cardiogenic Shock

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Background:

• Mechanical circulatory support is crucial for managing advanced cardiogenic shock.
• Extracorporeal membrane oxygenation (ECMO) is a key intervention for preventing multi-organ failure and mortality in these patients.

Purpose of the Study:

• To describe the experience and outcomes of using venoarterial ECMO (VA-ECMO) for advanced cardiogenic shock.
• To evaluate VA-ECMO as a bridge to recovery (BTR) or bridge to next decision (BTD).

Main Methods:

• Retrospective review of 155 patients treated with VA-ECMO for advanced cardiogenic shock at Penn State Medical Center over five years.
• Analysis of one-year survival rates based on underlying heart disease etiology (ischemic vs. non-ischemic).

Main Results:

• VA-ECMO has been integrated into routine care for over 200 patients.
• One-year survival rate was 73.7% for patients with ischemic heart disease.
• One-year survival rate was 75% for patients with non-ischemic heart disease.

Conclusions:

• VA-ECMO is a viable and effective therapeutic option for advanced cardiogenic shock.
• Successful ECMO treatment is associated with favorable long-term survival outcomes, regardless of heart disease type.